[ad_1]
DECLARETIMI 58 study on antidiabetic dapagliflozin nna-leb.gov.lb
National – The results of DECLARE – the largest clinical study conducted to evaluate a new clbad of type 2 antidiabetic drugs called "SGLT-2 inhibitors" – were presented during the first …
[ad_2]Source link
